A detailed history of Primecap Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Primecap Management CO holds 19,618,082 shares of LLY stock, worth $17.8 Billion. This represents 13.05% of its overall portfolio holdings.

Number of Shares
19,618,082
Previous 21,254,190 7.7%
Holding current value
$17.8 Billion
Previous $16.5 Billion 7.42%
% of portfolio
13.05%
Previous 12.54%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $1.19 Billion - $1.49 Billion
-1,636,108 Reduced 7.7%
19,618,082 $17.8 Billion
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $560 Million - $750 Million
-946,344 Reduced 4.26%
21,254,190 $16.5 Billion
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $453 Million - $534 Million
-863,002 Reduced 3.74%
22,200,534 $12.9 Billion
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $210 Million - $289 Million
-482,665 Reduced 2.05%
23,063,536 $12.4 Billion
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $639 Million - $854 Million
-1,821,349 Reduced 7.18%
23,546,201 $11 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $163 Million - $191 Million
-524,475 Reduced 2.03%
25,367,550 $8.71 Billion
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $683 Million - $796 Million
-2,125,130 Reduced 7.59%
25,892,025 $9.47 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $125 Million - $142 Million
-421,333 Reduced 1.48%
28,017,155 $9.06 Billion
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $121 Million - $142 Million
-434,743 Reduced 1.51%
28,438,488 $9.22 Billion
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $192 Million - $238 Million
-817,450 Reduced 2.75%
28,873,231 $8.27 Billion
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $677 Million - $840 Million
-3,010,305 Reduced 9.21%
29,690,681 $8.2 Billion
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $279 Million - $343 Million
-1,258,281 Reduced 3.71%
32,700,986 $7.56 Billion
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $256 Million - $331 Million
-1,418,968 Reduced 4.01%
33,959,267 $7.79 Billion
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $227 Million - $293 Million
-1,378,950 Reduced 3.75%
35,378,235 $6.61 Billion
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $159 Million - $210 Million
-1,218,139 Reduced 3.21%
36,757,185 $6.21 Billion
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $242 Million - $280 Million
-1,652,633 Reduced 4.17%
37,975,324 $5.62 Billion
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $315 Million - $379 Million
-2,307,345 Reduced 5.5%
39,627,957 $6.51 Billion
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $142 Million - $175 Million
-1,189,416 Reduced 2.76%
41,935,302 $5.82 Billion
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $31.3 Million - $38.8 Million
293,082 Added 0.68%
43,124,718 $5.67 Billion
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $35.4 Million - $38.5 Million
-331,484 Reduced 0.77%
42,831,636 $4.79 Billion
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $8.26 Million - $9.65 Million
-74,584 Reduced 0.17%
43,163,120 $4.78 Billion
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $820 Million - $965 Million
-7,365,752 Reduced 14.56%
43,237,704 $5.61 Billion
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $444 Million - $497 Million
-4,188,112 Reduced 7.64%
50,603,456 $5.86 Billion
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $26.7 Million - $33.4 Million
-310,946 Reduced 0.56%
54,791,568 $5.88 Billion
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $42.1 Million - $48.3 Million
555,731 Added 1.02%
55,102,514 $4.7 Billion
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $45 Million - $53.1 Million
-605,794 Reduced 1.1%
54,546,783 $4.22 Billion
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $43.4 Million - $46.6 Million
-529,945 Reduced 0.95%
55,152,577 $4.66 Billion
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $4.29 Billion - $4.76 Billion
55,682,522
55,682,522 $4.76 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.